SEC Filing « Sabre

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Moore David D

(Last)

(First)

(Middle)

C/O SABRE CORPORATION

3150 SABRE DRIVE

(Street)

SOUTHLAKE

76092

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/08/2020

3. Issuer Name and Ticker or Trading Symbol
Sabre Corp [ SABR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	94,443⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to Purchase Common Stock	⁽²⁾	07/15/2026	Common Stock	13,120	28.98	D
Options to Purchase Common Stock	⁽³⁾	03/15/2027	Common Stock	17,415	22.01	D
Options to Purchase Common Stock	⁽⁴⁾	03/15/2028	Common Stock	22,840	22.03	D
Options to Purchase Common Stock	⁽⁵⁾	03/15/2029	Common Stock	23,166	21.35	D
Options to Purchase Common Stock	⁽⁶⁾	10/15/2029	Common Stock	28,924	21.45	D
Options to Purchase Common Stock	⁽⁷⁾	03/13/2030	Common Stock	60,060	8.33	D

Explanation of Responses:

1. Includes the following grants of restricted stock units: (i)13,120 restricted stock units awarded on 7/15/2016. This restricted stock unit award vested as to 25% of the shares of common stock subject to such award on each of 7/15/2017 7/15/2018, and 7/15/2019 and will vest as to 25% on 7/15/2020. (ii) 16,484 restricted stock units awarded on 9/15/2017. This restricted stock unit award will vest 100% on 9/15/2020. (iii) 16,240 restricted stock units awarded on 8/15/2018.This restricted stock unit award vested as to 25% of the shares of common stock subject to such award on 8/15/2019, and will vest as to 25% of the shares on each of 8/15/2020, 8/15/2021 and 8/15/2022. (iv) 28,924 restricted stock units awarded on 10/15/2019. This restricted stock unit award will vest as to 25% of the shares on each of 10/15/2020, 10/15/2021, 10/15/2022, and 10/15/2023. All awards vestings are subject to the reporting person's continued employment on the vesting dates.

2. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of July 15, 2016 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

3. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2017 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

4. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2018 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

5. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of March 15, 2019 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

6. The options vest and become exercisable as to 25% of the shares of Common Stock of the Issuer subject to each such option on the first anniversary of the date of grant of October 15, 2019 and as to 6.25% of such shares at the end of each successive three-month period thereafter, subject to the reporting person's continued employment with the Issuer through each vesting date.

7. The options were granted on March 13, 2020 and vest and become exercisable in three equal installments of 33 1/3% on March 15, 2021, March 15, 2022 and March 15, 2023, subject to the reporting person's continued employment with the Issuer through each vesting date.

Remarks:

	/s/ Steve Milton, as attorney-in-fact for David D. Moore	06/17/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

          The undersigned does hereby constitute and appoint Steve Milton, Aimee Williams-Ramey and Carol Laico each of them, with full power to act alone, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, (1) to prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a)of the Securities Exchange Act of 1934, as amended  (the "Exchange Act") or any rule or regulation of the SEC and (2) to prepare, execute and acknowledge Forms 3, 4, 5 and 144 (including amendments thereto) with respect to securities of Sabre Corporation (the "Company"), and to deliver and file the same with all exhibits thereto, and all other documents in connection therewith, to and with the SEC, the national securities exchanges and the Company pursuant to Section 16(a) of the Exchange Act and the rules and regulations thereunder, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any one of them, or his substitute or their substitutes,  lawfully do or cause to be done by virtue hereof. The undersigned agrees that each of the attorney-in-fact herein may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact.

          The validity of this Power of Attorney shall not be affected in any manner by reason of the execution, at any time, of other powers of attorney by the undersigned in favor of persons other than those named herein.

           The undersigned agrees and represents to those dealing with any of the attorneys-in-fact herein that this Power of Attorney is for indefinite duration and may be voluntarily revoked only by written notice delivered to such attorney-in-fact.

           IN WITNESS WHEREOF, I have hereunto set my hand effective this 3rd day of June 2020.

/s/ David D. Moore
___________________
David D. Moore